Hand sanitizer and surface cleaner company Byotrol had a strong 2020 and are confident about 2021 Watch Now

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchison China Regulatory News (HCM)

Share Price Information for Hutchison China (HCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 489.00
Bid: 485.00
Ask: 489.00
Change: 1.00 (0.20%)
Spread: 4.00 (0.82%)
Open: 485.00
High: 490.00
Low: 473.00
Yest. Close: 488.00
HCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.
Date   Source Headline
29th Jan 20207:25 amRNSHolding(s) in Company
23rd Jan 20207:35 amRNSPricing of US$110 Million Public Offering of ADSs
22nd Jan 20207:00 amRNSChi-Med Announces Proposed Offering of ADSs
20th Jan 202010:40 amRNSPositive SANET-p Phase III Clinical Trial Results
13th Jan 20207:00 amRNSChi-Med Starts Surufatinib+PD-1 Ph2 Combo Trial
6th Jan 20207:04 amRNSChi-Med to Present at JP Morgan Conference
31st Dec 20197:00 amRNSBlock Listing Six Monthly Return
31st Dec 20197:00 amRNSTotal Voting Rights
20th Dec 20197:00 amRNSSurufatinib Granted Priority Review in China
12th Dec 20198:57 amRNSGrant of share options
29th Nov 20198:56 amRNSTotal Voting Rights
28th Nov 20197:00 amRNSElunate® Included in China NRDL
25th Nov 20197:47 amRNSChi-Med Highlights Presentations at 2019 ESMO Asia
25th Nov 20197:00 amRNSSurufatinib granted FDA orphan drug designation
11th Nov 20197:00 amRNSSurufatinib China NDA acceptance
17th Oct 20197:26 amRNSChi-Med Ph II gastric cancer data for Savolitinib
10th Oct 201910:22 amRNSGrant of share options under share option scheme
10th Oct 20199:00 amRNSInnovent and Chi-Med Expand Global Collaboration
4th Oct 20197:11 amRNSChi-Med Phase I/Ib Trial of HMPL-523 in Lymphoma
3rd Oct 20198:26 amRNSHolding(s) in Company
30th Sep 20191:49 pmRNSHolding(s) in Company
30th Sep 201912:11 pmRNSHolding(s) in Company
30th Sep 20197:00 amRNSChi-Med Surufatinib Phase III data at ESMO
30th Sep 20197:00 amRNSTotal Voting Rights
25th Sep 20197:00 amRNSChi-Med Presents SANET-ep Phase III data at ESMO
18th Sep 20197:00 amRNSChi-Med Highlights Presentations at 2019 CSCO
3rd Sep 20197:19 amRNSChi-Med to present at MS conference
3rd Sep 20197:00 amRNSChi-Med initiates Phase I trial
30th Aug 20197:00 amRNSTotal Voting Rights
23rd Aug 20197:00 amRNSStart of Clinical Trial in China
20th Aug 20197:48 amRNSHolding(s) in Company
30th Jul 201910:48 amRNSTR-1: Form for notification of major holdings
30th Jul 20197:00 amRNS2019 Interim Results and Clinical Programs Update
10th Jul 20194:35 pmRNSPrice Monitoring Extension
3rd Jul 20197:00 amRNSChi-Med to Announce 2019 Half-Year Results
3rd Jul 20197:00 amRNSTR-1: Form for notification of major holdings
28th Jun 201911:10 amRNSBlocklisting Six Monthly Return
28th Jun 201910:07 amRNSPricing of U.S. Public Secondary Offering of ADSs
28th Jun 20197:00 amRNSSecondary Offering of American Depositary Shares
21st Jun 20194:40 pmRNSSecond Price Monitoring Extn
21st Jun 20194:35 pmRNSPrice Monitoring Extension
19th Jun 20194:35 pmRNSPrice Monitoring Extension
14th Jun 20199:00 amRNSSurufatinib Phase III Study Meets Primary Endpoint
12th Jun 20199:18 amRNSBlock Admission Applications & Total Voting Rights
10th Jun 201912:07 pmRNSSecond Price Monitoring Extn
10th Jun 201912:02 pmRNSPrice Monitoring Extension
6th Jun 20197:00 amRNSDisclosure Update
31st May 20194:40 pmRNSSecond Price Monitoring Extn
31st May 20194:35 pmRNSPrice Monitoring Extension
29th May 201912:06 pmRNSResults of Extraordinary General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.